Upstream Bio, Inc. reports Q1 results (UPB:NASDAQ)
· seekingalpha.com
Upstream Bio (UPB) Q1 update: $1.03M revenue, $40.6M net loss on higher R&D, and $294.6M cash runway through 2027—read the highlights now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...